21Sep 2024
World alzheimer day
Why in the news? Two new drugs, Lecanemab (Leqembi) and Donanemab (Kisunla), have emerged as the first treatments capable of slowing Alzheimer’s progression. Developed by U.S. pharma companies Biogen, Eisai, and Eli Lilly, they represent a significant milestone after decades of research. Highlights of the Controversy Surrounding the Drugs: Despite their potential, the drugs have …
Read More